A little more than a week after the FDA rattled the biotech industry by rejecting Moderna's mRNA flu vaccine without even reviewing the application, the agency changed course. But there's a catch.
Copyright 2026 NPR
© 2026 WLRN
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
